TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 100 resultados LastUpdate Última actualización 27/01/2023 [14:02:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 4 nextPage   por página


SENSOR SYSTEMS, DEVICES, AND METHODS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2023017510A1 19/01/2023

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2019246960_A1

Resumen de: US2023017510A1

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

traducir

SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER

NºPublicación: US2023013632A1 19/01/2023

Solicitante:

DEXCOM INC [US]

AU_2022256146_A1

Resumen de: US2023013632A1

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

traducir

METHOD FOR MODIFICATION OF INSULIN DELIVERY DURING PREGNANCY IN AUTOMATIC INSULIN DELIVERY SYSTEMS

NºPublicación: US2023018355A1 19/01/2023

Solicitante:

INSULET CORP [US]

Resumen de: US2023018355A1

The disclosed embodiments are directed to methods for dynamically adjusting the total daily insulin requirements of a user during pregnancy, based on the gestational week. An initial estimate of the adjusted total daily insulin requirement may be calculated as a multiple of the pre-pregnancy total daily insulin requirement, based on an average scale factor from a population of pregnant women suffering from Type I diabetes mellitus. An automatic drug delivery device may adjust the initial estimate of the total daily insulin requirement based on blood glucose level readings from a continuous glucose monitor during the course of the pregnancy.

traducir

CANNULA INSERTION DETECTION

NºPublicación: US2023016823A1 19/01/2023

Solicitante:

BECTON DICKINSON CO [US]

ES_2886214_T3

Resumen de: US2023016823A1

Sensors are disclosed that detect whether a cannula is properly inserted to its full depth in a subject's skin. The sensors may be used with a blood glucose monitor, or with a continuous insulin infusion pump, infusion set, or other system involving intermittent or continuous testing and/or drug delivery.

traducir

INFUSION SYSTEM WITH CONCURRENT TPN/INSULIN INFUSION

NºPublicación: US2023017117A1 19/01/2023

Solicitante:

ICU MEDICAL INC [US]

AU_2015364478_A1

Resumen de: US2023017117A1

An infusion system to provide concurrent TPN/insulin infusion including: a fluid administration set having a primary line in fluid communication with the TPN source, a secondary line in fluid communication with the insulin source, and a common outlet line; a pump operable to removably receive the fluid administration set, the pump being operable to concurrently move the TPN solution through the primary line in response to a TPN solution flow rate signal and the insulin solution through the secondary line in response to an insulin solution flow rate signal; and a flow controller operable to provide the TPN solution flow rate signal and the insulin solution flow rate signal to the pump. The flow controller is further operable to vary the TPN solution flow rate signal and the insulin solution flow rate signal to vary a ratio of TPN solution to insulin solution provided to the common outlet line.

traducir

Apparatus to detect salt concentrations and glucose in bodily fluids

NºPublicación: US11553861B1 17/01/2023

Solicitante:

MY SALT AND SUGAR LLC [US]

Resumen de: US11553861B1

The present development is a method and device to monitor the salt level in a patient's blood without the need of laboratory facilities or intervention by medical personnel. The basic device is designed to measure the concentration of analytes, specifically sodium ion and potassium ion, in the patient's blood and to communicate the analyte level to the patient essentially instantaneously through a mobile monitor or display screen. In a variation, the device combines the analyte-concentration measuring function with a means for measuring the concentration of glucose in blood, and the blood analyte level and glucose level are displayed to the patient essentially instantaneously. Both the salt level device and the salt level+glucose level device may be further adapted to allow for the salt and glucose level data to be stored in a data storage base so the patient has an historical record of the concentration levels.

traducir

ANALYTE MONITORING SYSTEM AND METHODS OF USE

NºPublicación: US2023007916A1 12/01/2023

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2018364215_A1

Resumen de: US2023007916A1

The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.

traducir

INTEGRATED DISEASE MANAGEMENT SYSTEM

NºPublicación: US2023008055A1 12/01/2023

Solicitante:

EMBECTA CORP [US]

US_2021241905_A1

Resumen de: US2023008055A1

An integrated disease management system provides patients with simple, quick, and readily available counseling regarding a healthy diabetic lifestyle. The system can include an interactive engine with predictive analytics and machine learning to provide a customized experience for a user. The system can be configured to transmit data to a remote server to perform analysis of received data (e.g., disease management data), to provide feedback to the user (e.g., customized feedback with curated content based on a user's data and interface interactions) and send all or a portion of the data and/or curated content to another user device or remote health management access point (e.g., as cloud storage) where the information can be accessed by healthcare stakeholder.

traducir

PERITONEAL DIALYSIS SYSTEM

NºPublicación: US2023008094A1 12/01/2023

Solicitante:

MEDTRONIC INC [US]

Resumen de: US2023008094A1

In some examples, a system includes a glucose sensor configured to generate a signal indicative of a blood glucose level of a patient, a medical device configured to deliver insulin to the patient, a peritoneal dialysis (PD) device, and control circuitry. The control circuitry is configured to control the PD device to deliver PD therapy to a patient during a PD cycle, determine a blood glucose level of the patient during the PD cycle based on a signal from the glucose sensor, determine that the blood glucose level is greater than or equal to a predetermined blood glucose level threshold, and control the medical device to deliver insulin to the patient in response to determining the blood glucose level is greater than or equal to the predetermined blood glucose level threshold.

traducir

NON-INVASIVE BLOOD GLUCOSE DETECTOR AND DETECTION METHOD

NºPublicación: WO2023280017A1 12/01/2023

Solicitante:

WUXI KHOOO MEDICAL TECH CO LTD [CN]

CN_113261954_A

Resumen de: WO2023280017A1

A non-invasive blood glucose meter comprises a housing (1), a controller (2), a power supply module (3), cooling fins (4), a power switch (5), an LED light source (6), and a spectral sensor (7). A finger compartment (8) is provided in the housing (1); the power supply module (3) and the controller (2) are electrically connected to each other and are disposed in the housing (1); the LED light source (6) is disposed at the end of the finger compartment (8) and is located on the top surface of the finger compartment (8); the cooling fins (4) are connected to the spectral sensor (7); the spectral sensor (7) is located at the end of the finger compartment (8) and located on the bottom surface of the finger compartment (8); the LED light source (6) and the spectral sensor (7) are located on a same straight line. During non-invasive blood glucose detection, position limit, classification and recognition, detection position determining, and fingertip pressing degree determining can be performed on the finger before non-invasive blood glucose detection, and most stable spectral detection is performed on the finger when all interference factors are minimized.

traducir

LIQUID MEDICINE INJECTION DEVICE

NºPublicación: US2023011504A1 12/01/2023

Solicitante:

EOFLOW CO LTD [KR]

EP_4056211_PA

Resumen de: US2023011504A1

The present disclosure relates to a liquid medicine injection device including a patch portion to which a sensor portion configured to measure blood glucose is detachable and in which an injection portion configured to inject a liquid medicine into the body of a user is installed, and a stamping portion on which the patch portion is mounted and including a first needle connectable to the sensor portion, wherein the stamping portion transmits power to the patch portion so that the first needle and a second needle, which is connected to the injection portion, are together inserted into the skin of the user, and the sensor portion and the injection portion are installed in a single device so that the convenience of use is improved when the liquid medicine injection device is attached to the skin of the user.

traducir

ARRANGEMENT FOR OPERATING A BIOSENSOR AND ARRANGEMENT FOR DETERMINING THE GLUCOSE CONTENT IN THE BLOOD

NºPublicación: US2023011856A1 12/01/2023

Solicitante:

EYESENSE GMBH [DE]

CN_115053120_PA

Resumen de: US2023011856A1

An arrangement for operating a biosensor emitting radiation includes an excitation light source, which generates at least one excitation radiation for the biosensor; a coupling fiber, at the entry surface of which the excitation radiation is coupled in; an optical Y-coupler, including an excitation arm, which is connected to the exit surface of the coupling fiber, a detector arm, which is connected to an optical detector, and a sensor foot, which can be connected to the biosensor. The excitation arm has a conical shape. The radiation axis of the excitation arm includes an angle in the range of 5° to 70° with the main radiation axis of the detector arm. The diameter of the excitation arm at the connecting point to the detector arm is less than two thirds the diameter of the detector arm. An arrangement for determining the glucose content blood is also provided.

traducir

APPARATUS AND METHOD FOR ESTIMATING BIOLOGICAL INFORMATION

NºPublicación: US2023009905A1 12/01/2023

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: US2023009905A1

An apparatus for estimating blood glucose is provided. The apparatus for estimating blood glucose may include a spectrometer configured to measure a spectrum from an object, and a processor configured to monitor a change in a contact state between the object and the spectrometer, determine a calibration section based on the monitored change in the contact state, extract a background signal from a spectrum of the determined calibration section, and generate a personalized blood glucose estimation model based on the extracted background signal.

traducir

TECHNIQUES FOR RECOMMENDING RESCUE CARBOHYDRATE INGESTION IN AUTOMATIC MEDICATION DELIVERY SYSTEMS

NºPublicación: US2023011699A1 12/01/2023

Solicitante:

INSULET CORP [US]

Resumen de: US2023011699A1

Provided are techniques, devices and systems that include monitoring a trend of blood glucose measurement values over a series of measurement cycles. A processor may identify a potential excursion outside a range of a target blood glucose measurement value setting of a user based on the monitored trend. In response to the identified potential excursion, an alert may be generated to the user to consume rescue carbohydrates. In addition, the disclosed techniques may include a processor that assesses the factors related to a potential impending hypoglycemic event for a user. Based on a result of the assessment of the factors, the processor may determine whether the user is approaching the potential impending hypoglycemic event for the user. In response to a determination that the user is approaching the potential impending hypoglycemic event for the user, a number of rescue carbohydrates to suggest for consumption by the user may be determined.

traducir

CONTINUOUS GLUCOSE MONITORING DEVICE

NºPublicación: US2023008671A1 12/01/2023

Solicitante:

ZENSE LIFE INC [US]

CN_112292078_A

Resumen de: US2023008671A1

A wire-based three-pole sensor for subcutaneous insertion includes a working electrode including a first split wire having a first flat surface, and a support sheet on the first flat surface. The first flat surface is created from a full wire having a circular cross-section with a portion removed. A reference electrode includes a second split wire having a second flat surface. The second flat surface is defined by a second chord across a circular cross-section of the second split wire. A counter electrode includes a third split wire having a third flat surface. The third flat surface is defined by a third chord across a circular cross-section of the third split wire. The second and third flat surfaces face each other. A cross-sectional diameter of the first split wire, the second split wire, and the third split wire coupled together is less than an inner diameter of an insertion needle.

traducir

SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY

NºPublicación: US2023009339A1 12/01/2023

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2020108204_A1

Resumen de: US2023009339A1

The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.

traducir

DEVICE FOR CONTROLLING INJECTION OF MEDICINAL FLUID

NºPublicación: EP4115927A1 11/01/2023

Solicitante:

EOFLOW CO LTD [KR]

CN_115243747_PA

Resumen de: EP4115927A1

Provided is a liquid medication control injection device including a blood glucose measuring unit configured to measure blood glucose of target of injection at least a plurality of times, sequentially, a first liquid medication injection unit configured to inject a first liquid medication containing a component for controlling a decrease in blood glucose of the target of injection to the target of injection, and a second liquid medication injection unit configured to inject a second liquid medication containing a component for controlling an increase in blood glucose of the target of injection, wherein the component of the second liquid medication is different from that of the first liquid medication.

traducir

PANCREATIC CELL RECEIVING MATRIX AND IMPROVED ARTIFICIAL PANCREAS DEVICE

NºPublicación: WO2023275134A1 05/01/2023

Solicitante:

UNIV GRENOBLE ALPES [FR]
CENTRE HOSPITALIER UNIV GRENOBLE ALPES [FR]
INST POLYTECHNIQUE GRENOBLE [FR]
CENTRE NAT RECH SCIENT [FR]

FR_3124695_PA

Resumen de: WO2023275134A1

The invention relates to a pancreatic cell receiving matrix (1) comprising a semi-permeable wall (10) and a porous body (12) comprising a first set (120) of cavities (1200) comprising pancreatic cells (13), and a second set (121) of cavities (1210) free of pancreatic cells. The first set (120) of cavities and the second set (121) of cavities are not fluidically connected to one another. The cavity or cavities (1210) left free of cells create paths for the nutrients and gases to diffuse in the matrix (1), and they form a nutrient and gas reserve area in the matrix. The matrix (1) limits and preferably prevents nutrient and gas depletion of the pancreatic cells (13). Their mortality is therefore reduced, allowing better insulin delivery.

traducir

STACKED TISSUE ENCAPSULATION DEVICE SYSTEMS WITH OR WITHOUT OXYGEN DELIVERY

NºPublicación: US2023000612A1 05/01/2023

Solicitante:

UNIV ARIZONA [US]

KR_20220149620_PA

Resumen de: US2023000612A1

Systems featuring two or more encapsulation devices stacked together. The encapsulation devices house cells, such as but not limited to islet cells or stem cell derived beta cells or the like. e.g., for regulating blood glucose, or other cells or spheroids that can produce and release a therapeutic agent that is useful in the body, etc. The system may feature oxygen delivery, or in some cases no exogenous oxygen is delivered and vascularization of the device can help provide oxygen and other needed nutrient to the cells. The system of the present invention may be used in conjunction with other therapies such as an artificial pancreas. Stacking the devices with blood vessel formation around and in between them may allow for a decrease in the footprint that would be needed for implantation.

traducir

Glucose alert prediction horizon modification

NºPublicación: AU2021336883A1 05/01/2023

Solicitante:

DEXCOM INC

WO_2022051411_A1

Resumen de: AU2021336883A1

Data describing glucose measurements is received from a continuous glucose monitoring (CGM) system worn by a user and predicted glucose values during a future time period are generated for the user based on the data. A determination is made that at least one of the predicted glucose values satisfies a threshold value for an alert, which is associated with a prediction horizon that defines an amount of time prior to satisfaction of the threshold value for communicating the alert to the user. Output of the alert is caused responsive to determining that the at least one predicted glucose value satisfies the threshold value for the alert within the prediction horizon, relative to a current time. The prediction horizon is modified based on a user response to the alert. Output of a subsequent instance of the alert is caused based on the modified prediction horizon.

traducir

GLUCOSE SENSOR IDENTIFICATION USING ELECTRICAL PARAMETERS

NºPublicación: US2023004815A1 05/01/2023

Solicitante:

MEDTRONIC MINIMED INC [US]

CN_115553767_PA

Resumen de: US2023004815A1

An example method for calibrating a glucose sensor includes determining, by one or more processors, a set of electrical parameters for the glucose sensor of a plurality of glucose sensors and determining, by the one or more processors, a cluster for the glucose sensor based on the set of electrical parameters. Each cluster of the plurality of clusters identifies respective configuration information. In this example, the method includes configuring, by the one or more processors, the glucose sensor to determine a glucose level of a patient based on configuration information identified by the determined cluster.

traducir

CONNECTORS FOR MAKING CONNECTIONS BETWEEN ANALYTE SENSORS AND OTHER DEVICES

NºPublicación: US2023000400A1 05/01/2023

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2022047186_A1

Resumen de: US2023000400A1

Glucose monitoring devices and related systems and methods, the glucose monitoring devices including a sensor electronics unit having a housing and a printed circuit board disposed within the housing, a transcutaneous glucose sensor assembly, and a conductive sensor connector. The printed circuit board includes a first electrical contact, the transcutaneous glucose sensor assembly includes a distal portion having a working electrode and proximal portion having a working-electrode contact in electrical communication with the working electrode, and the conductive sensor connector electrically connects the working-electrode contact with the first electrical contact. Further, the conductive sensor connector extends through a hole in the proximal portion of the transcutaneous glucose sensor assembly and through a hole in the printed circuit board.

traducir

METHODS, SYSTEMS, AND DEVICES FOR CALIBRATION AND OPTIMIZATION OF GLUCOSE SENSORS AND SENSOR OUTPUT

NºPublicación: US2023000402A1 05/01/2023

Solicitante:

MEDTRONIC MINIMED INC [US]

CN_114983402_A

Resumen de: US2023000402A1

A continuous glucose monitoring system may utilize externally sourced information regarding the physiological state and ambient environment of its user for externally calibrating sensor glucose measurements. Externally sourced factory calibration information may be utilized, where the information is generated by comparing metrics obtained from the data used to generate the sensor's glucose sensing algorithm to similar data obtained from each batch of sensors to be used with the algorithm in the future. The output sensor glucose value of a glucose sensor may also be estimated by analytically optimizing input sensor signals to accurately correct for changes in sensitivity, run-in time, glucose current dips, and other variable sensor wear effects. Correction actors, fusion algorithms, EIS, and advanced ASICs may be used to implement the foregoing, thereby achieving the goal of improved accuracy and reliability without the need for blood-glucose calibration, and providing a calibration-free, or near calibration-free, sensor.

traducir

EVENT-ORIENTED PREDICTIONS OF GLYCEMIC RESPONSES

NºPublicación: US2023000447A1 05/01/2023

Solicitante:

MEDTRONIC MINIMED INC [US]

WO_2023278653_PA

Resumen de: US2023000447A1

Disclosed herein are techniques related to event-oriented predictions of glycemic responses. In some embodiments, the techniques may involve accessing a prediction model that correlates a person's glycemic responses to events and the person's physiological parameters during the events. The techniques may also involve obtaining a glucose level measurement of the person during an event. Additionally, the techniques may involve determining, based on the glucose level measurement, a physiological parameter of the person during the event. Furthermore, the techniques may involve predicting the person's glycemic response to the event based on applying the prediction model to the physiological parameter.

traducir

A syringe, a method for manufacturing such syringes and an assembly

Nº publicación: AU2020443532A1 05/01/2023

Solicitante:

MEDTECH CONCEPT LLC

BR_112022021410_PA

Resumen de: AU2020443532A1

A syringe, having a front portion carrying a hollow, axially extending needle, a container, running from said front portion and forming a container rear end portion, a plunger, extending and being movable axially in the container, the needle rear end being in fluid connection with the container and the plunger being arranged to suck liquid, e.g. a liquid comprising insulin, through the needle when drawn away from the needle and to discharge liquid through the needle when pushed towards the needle, the plunger having a piston portion, turned t the needle rear end, and a coupling portion arranged to co-act with the piston portion for moving the piston portion in the container.

traducir

Página1 de 4 nextPage por página

punteroimgVolver